- Summits
- Sponsorship
- Get Tickets
- Retreats
- Media Opportunities
- News
- About
With MedTech World’s Asia flagship taking place tomorrow at the Hong Kong Convention and Exhibition Centre, the countdown is being felt well beyond the exhibition floor. Dr. Dylan Attard, CEO and co-founder of MedTech World, joined RTHK’s Money Talk, the broadcaster’s fast-paced business and finance programme, to preview the summit, running 26 to 28 August, and to unpack why Hong Kong has become the organisation’s next big bet in Asia.
Money Talk covers breaking business news and market developments, and the conversation with Dr. Attard set out to answer a simple question: why is one of the world’s fastest-growing MedTech events landing in Hong Kong, and what should the city’s investors, hospitals, and innovators expect from it?
Listen to the full interview here:
Dr. Attard traced MedTech World’s origins back to his own surgical training in Malta roughly six years ago, when he noticed governments, accelerated by the pandemic, beginning to pour real attention and capital into medical devices, health tech, and life sciences. What started as a single annual conference promoting Malta as a MedTech hub has since expanded into a series of flagship events spanning Dubai, Florida, and Malta, with Hong Kong now firmly in the mix.
“I’m looking to call Hong Kong our home for the next couple of years,” he told the programme, describing the city as sitting at the heart of Asia, well-connected to the rest of the region, and backed by strong capital appetite and government-level support, from the Hong Kong Science and Technology Park to the city’s trade and investment bodies.
Asked where he’s seeing the most momentum, Dr. Attard pointed to robotics as one of MedTech’s most visible growth areas, already reshaping surgery and other hospital specialties through faster procedures and better patient recovery. He also flagged artificial intelligence as a force multiplier across the healthcare pathway, from easing administrative load on physicians to sharpening diagnostic precision in fields like radiology.
Life sciences and biotech rounded out his list, with Hong Kong’s public stock exchange singled out as a genuine advantage: a track record of successful listings that has helped build investor confidence in the wider ecosystem.
Dr. Attard pushed back on the long-standing perception that MedTech and HealthTech struggle to attract investment. The numbers, he argued, tell a different story, particularly across the regions where MedTech World now operates. What has changed, he said, is precision: investors are increasingly selective, weighing not just novelty but real impact on patients and health systems, while startups themselves are becoming choosier about the capital they accept, looking for partners who bring hospital connections, trial access, and a route to expansion across Asia, Europe, or North America.
That two-way selectivity, he said, is exactly why MedTech World sees its role as more than event organiser. A Maltese government delegation from the Ministry of Health will join the Hong Kong summit, part of a broader push to connect the city’s ecosystem with partners well beyond Asia.
The conversation closed on a theme Dr. Attard sees running through the entire industry: a shift from treating illness to preventing it. He described a growing ideology across medical devices and digital health, one focused less on treatment after diagnosis and more on helping people live longer, healthier lives well into their 70s and 80s. It’s a longevity-driven mindset, he noted, and Asia is emerging as one of its most active testing grounds.
MedTech World Asia takes place 26 to 28 August at the HKCEC, bringing together startups, investors, hospitals, and government stakeholders from across the region and beyond. With the MedTech World Match app, attendees can schedule 1:1 meetings, explore the event agenda, and plan their time at the summit. There’s still time to book your ticket and join the MedTech and HealthTech community in Hong Kong.
